The Royal Society organised a workshop that brought together international academic experts and members of the OECD Working Party on Manufactured Nanomaterials (WPNM). This report summarises the main issues discussed during the workshop.
English, , 553kb
This case studies report is part of the OECD effort to develop guidance for regulatory applications of (Quantitative) Structure-Activity Relationship [(Q)SAR] models, and emphasizes the use of programme-specific case studies.
English, , 2,675kb
This article shows the possible opportunities and risks of nanotechnologies today.
This document provides information on current/planned activities related to the safety of manufactured nanomaterials in OECD countries. Information was provided as written reports by delegations who participated in the 1st Meeting of OECD's Working Party on Manufactured Nanomaterials.
The main objectives of the workshop were: i) to discuss the history and evolution of the conceptual framework for the evaluation of transgenic plant products in the environment and OECD’s role in the development of that framework; ii) to discuss the current contribution of OECD’s Working Group for the Harmonization of Regulatory Oversight in Biotechnology to risk/ safety assessment practice; and iii) to discuss current risk assessment
Report of the OECD Pesticide Risk Reduction Steering Group Seminar on Risk Reduction through Good Pesticide Labelling - Series on Pesticides N°29
Report of the OECD Pesticide Risk Reduction Steering Group: The Second Risk Reduction Survey - Series on Pesticides n°30
In a speech at the Annual Conference of the Club de Madrid, Angel Gurría focussed on the political economy of climate policies. He spoke about a range of policies that could be used to help address climate change, and the considerable challenges of implementing them.
English, , 1,610kb
The objective of the workshop was to identify and review the kinds of baseline information of (non-transgenic) traditional fish farming or breeding, and to determine what information might be relevant to risk/ safety assessment.
Publications on Harmonisation of Regulatory Oversight in Biotechnology